Therefore, in this study, we performed a comprehensive bioinformatics analysis of GPS1 expression in breast cancer using the Cancer Genome Atlas (TCGA) public database, the Tumor Immunity Evaluation (TIMER) database, and the UALCAN database; and assessed the prognostic value of GPS1 using the Kaplan–Meier Plotter database. Here, GPS1 is linked to breast carcinoma.